These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6765543)

  • 1. Comparative study of NPH human insulin (recombinant DNA) and pork insulin in diabetic subjects: preliminary report.
    Mirouze J; Monnier L; Richard JL; Gancel A; Soua KB
    Diabetes Care; 1982; 5 Suppl 2():60-2. PubMed ID: 6765543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human (recombinant DNA) and porcine NPH insulins are unequally effective in diabetic patients. A comparative study using continuous blood glucose monitoring.
    Richard JL; Rodier M; Cavalié G; Mirouze J; Monnier L
    Acta Diabetol Lat; 1984; 21(3):211-7. PubMed ID: 6393670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of NPH human insulin (recombinant DNA) and NPH bovine insulin in diabetic subjects.
    Marre M; Tabbi-Anneni A; Tabbi-Anneni H; Assan R
    Diabetes Care; 1982; 5 Suppl 2():63-6. PubMed ID: 6765544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crossover study with human insulin (recombinant DNA) in type I diabetic subjects.
    Landgraf R; Kammerer S; Bock T; Smolka B; Ladik T; Enzmann F; Landgraf-Leurs MM
    Diabetes Care; 1982; 5 Suppl 2():39-42. PubMed ID: 6765538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the activity profiles of two fixed combinations of regular/NPH human insulin (recombinant DNA) of different compositions with a fixed regular/NPH porcine insulin combination (PPI) in insulin-dependent diabetic individuals.
    Sailer D; Ludwig T; Kolb S
    Diabetes Care; 1982; 5 Suppl 2():57-9. PubMed ID: 6765542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with human insulin (recombinant DNA) in diabetic subjects pretreated with pork or beef insulin: first results of a multicenter study.
    Beyer J; Enzmann F; Lauerbach M; Althoff P; Bachmann W; Brandstetter K; Cordes U; Dannehl A; Düntsch G; Haas R
    Diabetes Care; 1982; 5 Suppl 2():140-8. PubMed ID: 6765526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of semisynthetic human NPH insulin and porcine NPH insulin in the treatment of insulin-dependent diabetes mellitus.
    Pedersen C; Høegholm A
    Diabet Med; 1987; 4(4):304-6. PubMed ID: 2956040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.
    Hermansen K; Madsbad S; Perrild H; Kristensen A; Axelsen M
    Diabetes Care; 2001 Feb; 24(2):296-301. PubMed ID: 11213882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for the most practical regular/NPH mixtures for type I diabetic patients.
    Renner R; Vocke K; Hepp KD
    Diabetes Care; 1982; 5 Suppl 2():53-6. PubMed ID: 6765541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes.
    Raskin P; Klaff L; Bergenstal R; Hallé JP; Donley D; Mecca T
    Diabetes Care; 2000 Nov; 23(11):1666-71. PubMed ID: 11092290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind crossover trial comparing human insulin (recombinant DNA) with animal insulins in the treatment of previously insulin-treated diabetic patients.
    Clark AJ; Wiles PG; Leiper JM; Knight G; Adeniyl-Jones RO; Watkins PJ; Ward JD; MacCuish AC; Keen H; Jones RH
    Diabetes Care; 1982; 5 Suppl 2():129-34. PubMed ID: 6765523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The U.S. "new patient" and "transfer" studies.
    Galloway JA; Peck FB; Fineberg SE; Spradlin CT; Marsden JH; Allemenos D; Ingulli-Fattic J
    Diabetes Care; 1982; 5 Suppl 2():135-9. PubMed ID: 6765525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group.
    Rosenstock J; Park G; Zimmerman J;
    Diabetes Care; 2000 Aug; 23(8):1137-42. PubMed ID: 10937511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulin.
    Thow JC; Johnson AB; Marsden S; Taylor R; Home PD
    Diabet Med; 1990 Nov; 7(9):795-9. PubMed ID: 2148131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
    Ahmed AB; Mallias J; Home PD
    Diabetes Care; 1998 Jul; 21(7):1162-6. PubMed ID: 9653613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine and human NPH insulins as T cell immunogens.
    Gregory R; Tattersall RB
    Diabetes Res Clin Pract; 1993 May; 20(2):139-46. PubMed ID: 8375267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Insulin glargine improves fasting blood glucose levels in prepubertal children with unsatisfactorily controlled type 1 diabetes].
    Mianowska B; Szadkowska A; Czerniawska E; Pietrzak I; Bodalski J
    Pediatr Endocrinol Diabetes Metab; 2007; 13(4):189-93. PubMed ID: 18042313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of human insulin (recombinant DNA)--regular, NPH, and mixtures--obtained by the Gerritzen method in healthy volunteers.
    Weinges K; Ehrhardt M; Nell G; Enzmann F
    Diabetes Care; 1982; 5 Suppl 2():67-70. PubMed ID: 6765545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal provision of daytime NPH insulin in patients using the insulin analog lispro.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Oct; 21(10):1707-13. PubMed ID: 9773735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.
    Schober E; Schoenle E; Van Dyk J; Wernicke-Panten K;
    Diabetes Care; 2001 Nov; 24(11):2005-6. PubMed ID: 11679478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.